It has also been reported that in the context of FGFR2 genetic variants and breast cancer, lower FGFR2 expression is associated with increased response to estrogen (Campbell et al., 2016) and these FGFR2 variants are associated with poor prognosis (Castro et al., 2016). The gene discussed is FGFR2; the disease is breast carcinoma.